Related Experiment Video
Updated: May 31, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Thalassemia and venous thromboembolism
Julien Succar1, Khaled M Musallam, Ali T Taher
1Department of Internal Medicine, Hematology-Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon.
Summary
Thalassemia patients, especially those with thalassemia intermedia, face a higher risk of blood clots due to a hypercoagulable state. This review explores the underlying mechanisms and management strategies for these thrombotic events.
Area of Science:
- Hematology
- Vascular Biology
- Genetics
Background:
- Thalassemia, a congenital blood disorder, has seen improved life expectancy.
- However, patients experience significant complications, including a high incidence of thromboembolic events.
- Thalassemia intermedia patients exhibit a particularly pronounced hypercoagulable state.
Purpose of the Study:
- To review the molecular and cellular mechanisms driving hypercoagulability in thalassemia.
- To focus on the increased thrombotic risk in thalassemia intermedia compared to other forms.
- To discuss clinical experiences and potential management strategies for hypercoagulability.
Main Methods:
- Literature review focusing on molecular and cellular mechanisms of hypercoagulability.
- Analysis of studies comparing thrombotic event incidence across different thalassemia types.
- Synthesis of clinical data and management guidelines.
Main Results:
- Identified a hypercoagulable state in thalassemia patients, particularly thalassemia intermedia.
- Highlighted specific molecular and cellular pathways contributing to this prothrombotic condition.
- Thalassemia intermedia shows a significantly higher incidence of thrombotic events.
Conclusions:
- Hypercoagulability is a significant complication in thalassemia, especially thalassemia intermedia.
- Understanding the mechanisms is crucial for managing thrombotic risks.
- Further research and optimized clinical management are needed.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...